Measures to Identify, Diagnose and Treat Patients with Respiratory Tuberculosis in Inpatient Conditions during the Epidemic of Coronavirus Infection
The advent of SARS-CoV-2 has given health professionals the tasks related to rapid diagnosis and provision of medical services to patients, as well as the need to intensively study the clinical and epidemiological features of the disease, to develop new means of its prevention and treatment. Tuberculosis (TB) patients are considered one of the most vulnerable groups in the population. In such people, the lungs are affected and immunity is weakened, which makes this category of the population more severe, they more often have complications leading to death. These recommendations are based on materials on the diagnosis, prevention and treatment of COVID-19 and respiratory tuberculosis (RT), published by specialists from WHO, the Chinese, American and European prices for disease control, analysis of domestic and foreign scientific publications, regulatory documents of the Government of the Republic of Belarus and the Ministry of Health of the Republic of Belarus.